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CHAPTER 5
Use of video-consultation is feasible 
during follow-up care of patients with 
a neuroendocrine tumour
Grietje Bouma1, Lotte D. de Hosson1, Henny van Essen1, Elisabeth G.E. de Vries1, 
Derk Jan A. de Groot1, Annemiek M.E. Walenkamp1
1 Department of Medical Oncology, University of Groningen, 
University Medical Centre Groningen, Groningen, the Netherlands
Clin Oncol (R Coll Radiol). 2018; 30:396 (published as letter-to-the-editor) 
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Chapter 5
Abstract
Purpose 
Patients with a neuroendocrine tumour (NET) are increasingly treated in expert centers 
leading to longer travel times for medical consultations. Video-consultation (VC) 
potentially allows remote guidance of patients. Studies evaluating VC in NET patients 
are lacking. Therefore the primary aim of this study was to assess feasibility of VC during 
follow-up care of NET patients.
Methods 
Clinical stable NET patients (N = 20) received two VCs during follow-up care. Feasibility 
of VC was assessed by calculation of participation/drop-out rate and safety. Satisfaction 
questionnaires were filled out by patients and physicians. VC time, patient-reported travel 
time for an outpatient clinic visit and preference for type of consultation were noted.
Results 
Participation rate was 84%. Six of the 26 (23%) included patients terminated the 
study prematurely. No safety concerns were reported. Median score for satisfaction of 
patients and physicians were 4.6 (range 3.3-4.9, five-point Likert scale) and 4.0 (range 
3.5-4.9) respectively, indicating high satisfaction with VC. Technical problems leading to 
prolonged connection time and impaired audio/video quality were reported by 55% 
and 40% of the patients and physicians respectively. Median VC time was 13 minutes 
(range 9-25). Patient-reported duration of a follow-up consultation at the outpatient 
clinic was 240 minutes (range 100-390). Sixty percent of the patients preferred VC.
Conclusions 
Use of VC during follow-up care of patients with clinical stable NET is feasible. Patients’ 
and physicians’ acceptability and satisfaction with VC is high, but can be improved by 
solving technical problems.
Keywords: neuroendocrine tumour, video-consultation, communication, telemedicine.
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Use of video-consultation is feasible during follow-up care of patients with a neuroendocrine tumour
Introduction
Neuroendocrine tumours (NETs) are rare tumours [1,2]. The 5-year overall survival of NET 
patients with distant metastases is about 55% [2]. Therefore, NET patients often require 
for a long time frequent hospital visits. In the Netherlands, most NET patients are treated 
in ‘ENETS (European NeuroEndocrine Tumour Society) centers of excellence’ [3]. This 
coincides with often relatively long distance travel for a follow-up visit. Telemedicine uses 
information and communication technology to provide health care services to individuals 
who are at a distance from their health care provider [4]. The use of telemedicine in 
oncology (‘tele-oncology’) can be defi ned as the delivery of oncology services from a 
distance [5]. Nowadays, tele-oncology is also used for remote consultation, for example 
by video-consultation (VC). Despite this emerging technology, there is a lack of studies 
examining the use of VC in the care of cancer patients.
Replacing follow-up consultations at the outpatient clinic by VCs could save time for 
patients with a NET. Other benefi ts of using VC can be reduced cost, higher effi  ciency 
and increased convenience. Therefore, we aimed to study the feasibility of VC as an 
alternative for outpatient clinic consultations in NET patients receiving follow-up care.
Methods
Participants
Potential participants were NET patients under surveillance or receiving treatment 
at the Department of Medical Oncology at the University Medical Center Groningen 
(UMCG, the Netherlands). Eligible were patients with a medical condition which allowed 
VC (‘clinical stable’), as determined by the treating medical oncologist. Other eligibility 
criteria were age ≥18 years, grade I/II NET (according to the World Health Organization 
2010 classifi cation) and having access to required equipment/technology for performing 
VC.
Newly referred patients, patients in de diagnostic phase of their disease and patients 
requiring face-to-face consultation and/or physical examination were not eligible. Also, 
patients with a hearing or visual impairment were excluded.
Eligible patients were recruited until 20 participants had completed the study and 
accompanying questionnaires. Patients were included between May 2014 to September 
2015.
All participants gave written informed consent. The medical ethical committee of the 
UMCG did not review this study as they declared that this study did not fall under the 
scope of the Medical Research Involving Human Subjects Act and did not need review. 
The study was conducted in accordance with the Personal Data Protection Act and the 
Agreement on Medical Treatment Act. The study was registered in ClinicalTrials.gov 
(NCT02147106).
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Study procedure
In the present study, WebEx® was used for consultation by VC. WebEx® meets the safety 
requirements and regulations of the UMCG and is supported by the Information and 
Communication Technology Department of the UMCG. After having obtained written 
informed consent, participants received by mail baseline questionnaires regarding 
socio-demographic characteristics, experience with internet/video communication, 
the total time a conventional follow-up outpatient clinic consultation did take in the 
past and expectations about VC. Also, participants received a short introduction about 
installing WebEx® and using VC. Baseline questionnaires had to be returned before the 
first VC. The investigator contacted each participant to check if installation of WebEx® 
was successfully or otherwise to help with the installation. The participant received 
appointment letters for the VC. If indicated, participants received additionally a form 
for blood analysis which was performed in laboratories near the home of the patient. 
Results of the blood analysis were collected by the treating medical oncologist before 
the VC. If possible, VCs were alternately planned with an outpatient clinic consultation. 
End of study was reached after completion of two VCs, which had to take place within 
one year, and accompanying questionnaires. At end of study, the patient received by 
mail questionnaires regarding acceptability and satisfaction with VC, preference for 
type of consultation and their opinion on using VC. The physician documented after 
each VC the duration of and reason for VC. Also, after each VC the physician completed 
a post-intervention questionnaire regarding acceptability and satisfaction with VC. 
An additional outpatient clinic consultation would be planned within 1 week (e.g. for 
physical examination or other in-hospital procedures), if this was indicated during VC. 
Details of the consultation by VC were documented in the medical record according 
to a standard format developed by the investigator. As in a conventional follow-up 
outpatient clinic consultation, a letter pertaining to the consultation was sent to the 
patient’s general practitioner and/or referring physician.
Outcome measures
At baseline, socio-demographical characteristics and experience with internet/
videocommunication (e.g. Skype, FaceTime) was assessed by a self-report questionnaire. 
Collection of illness-related characteristics was done by examination of the medical 
records. The distance of the patients home to the UMCG was calculated in kilometers 
from the patient’s postal code to the postal code of the UMCG using maps.google.com.
To evaluate the primary endpoint feasibility the participation and drop-out rates were 
calculated. Also, reason for declining participation, reason for drop-out and safety 
concerns (e.g. additional outpatient clinic visits, hospitalization and interventions) were 
noted.
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To explore the by VC saved amount of time for patients, the participants were asked 
to estimate the total time they spent on a conventional follow up outpatient clinic 
consultation in the past (leaving home for the consultation till arriving at home, in 
minutes). The duration of each VC was documented by the physician.
Patients’ acceptability and satisfaction with VC was investigated with an in Dutch 
translated adapted version of the validated Telemedicine Satisfaction Questionnaire 
(TSQ) [6]. The questionnaire consists of 14 items, representing three aspects of patient 
satisfaction with telemedicine: ‘quality of care provided’ (item 5, 7, 8, 10, 11, 13-15), 
‘similarity to face-to-face encounter’ (item 1-4, 9) and ‘perception of the interaction’ 
(item 6). Each item is rated using a fi ve-point Likert scale. Higher scores indicate greater 
satisfaction with telemedicine. At baseline, participants were asked to fi ll out an adapted 
version consisting of 12 items instead of 14 (2 post-intervention items were deleted). 
The items were adapted so they indicate the patients’ expectations of VC. At end of 
study, participants had to fi ll out the original 14-item TSQ. In both TSQs ‘telemedicine’ 
was replaced by ‘video-consultation’. Also, participants were asked about their opinion 
on using VC (e.g. open-ended questions regarding benefi ts, drawbacks, (technical) 
problems, necessary improvements) and which follow-up consultation they prefer: 
‘outpatient clinic consultation’, ‘video-consultation’ or ‘no preference’.
Physicians’ acceptability and satisfaction with VC was investigated with a self-developed 
post-intervention questionnaire after each VC. The fi rst part of the questionnaire consists 
of 6 statements about performing VC. Each item is rated with a fi ve-point Likert scale. 
Higher scores indicate greater satisfaction with VC. The second part of the questionnaire 
is composed of open-ended questions regarding (dis-)advantages of using VC for 
patients and physicians. Also, the physician had the possibility to note improvements 
regarding VC.
Statistical analysis
Seen the small available group of patients due to the rarity of NET and the primary aim 
to assess feasibility a sample size was set at 20 patients.
Given the explorative nature of this study descriptive analyses (e.g. means, medians, 
ranges, frequencies) were calculated for all measures. Analyses were performed using 
the software package SPSS, version 22 for Windows (SPSS, Inc, Chicago, IL, USA).
Results
Participants and feasibility of video-consultation
Figure 1 summarizes the enrollment and fl ow of participants. Twenty-six of the 31 
(84%) invited patients for study participation were included. Six participants did not 
Use of video-consultation is feasible during follow-up care of patients with a neuroendocrine tumour
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complete the full study (drop-out rate 23%). One participant died due to progressive 
disease. Patient characteristics are summarized in Table 1. Thirteen of the 20 patients 
were known with NET for more than three years. The drop-outs had a median age at 
inclusion of 58 years (range 50-67) and 83% had used videocommunication for personal 
use or work purposes in the past. No additional visits to the outpatient clinic/hospital or 
interventions related to VCs were done.
Figure 1. Flow diagram
This flow diagram shows the flow of invited and included patients with reasons for declining 
study participation and drop-out.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 invited patients 
26 participants with 
written informed consent 
Reason for no study participation: 
 Preference of patient for consultation outpatient clinic 
(N = 1) 
 No experience with internet (N = 2) 
 Medical condition does not allow video-consultation 
according to treating medical oncologist (N = 2) 
 
20 participants completed 
the trial period 
Reason for drop-out: 
 Withdrawal by physician: preference for visit 
outpatient clinic (N = 1) 
 Technical problems (N = 2) 
 Death of patient (N = 1) 
 Patient received treatment in other hospital after the 
first video-consultation (N = 1) 
 
 
First video-consultation  
Reason for drop-out: 
 Medical condition does not allow video-consultation 
according to treating medical oncologist (N = 1) 
 
 
Second video-consultation 
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Table 1. Patient characteristicsa (N = 20) 
a Data are expressed as number (percentage) unless noted otherwise
b Union for International Cancer Control
c Three patients on a somatostatin analogue also used everolimus (N = 1) or interferon (N = 2)
d Proton pump inhibitor
Sex male/female    15/5 (75/25) 
Median age at inclusion in years (range)       64 (47-73) 
Median distance to hospital in kilometers (range)         75 (31-218) 
Educational level 
   Lower vocational level 
   Intermediate vocational level 
   Higher vocational level 
 
  2 (10) 
  5 (25) 
13 (65) 
Employment status  
   Employed 
   Unemployed 
 
     7 (35%) 
   13 (65%)  
Marital status  
   Married/cohabiting 
   Living alone 
 
16 (80) 
  4 (20) 
Patients with children               17 (85) 
Use of internet in daily life    20 (100) 
Use of video-communication in daily life  11 (55) 
Median age at diagnosis in years (range)      56 (45-70) 
Location primary tumour  
   Duodenum 
   Pancreas 
   Jejunum/ileum 
   Colon 
   Unknown 
 
1 (5) 
  4 (20) 
10 (50) 
1 (5) 
  4 (20) 
NET disease stage (according to UICCb) 
   Stage II 
   Stage IV 
 
1 (5) 
19 (95) 
Patients receiving treatment at inclusion   20 (100) 
Treatment at inclusion studyc 
   Somatostatin analogue 
   Everolimus 
   Interferon 
   Otherd 
 
16 (80) 
  3 (15) 
  2 (10) 
  2 (10) 
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Duration of outpatient clinic consultation and video-consultation
The patient-reported median duration of a conventional follow-up outpatient clinic 
consultation was 240 minutes (range 100-390). The median duration of a VC was 13 
minutes (range 9-25).
Patients’ acceptability and satisfaction with video-consultation
At baseline, mean scores on patients’ expectations of VC were high (Table 2). Item 4 
which is related to the domain ‘similarity to face-to-face encounter’ and item 8 (related 
to the domain ‘quality of care’) were scored lower. At end of study, participants expressed 
high levels of satisfaction with VC (median 4.6 (range 3.3-4.9), Table 3). The score on item 
8 did not improve after having done VC. The scores indicate that participants find VC 
of good quality and timesaving and are interested to use VC again. At end of study, 12 
out of 20 participants preferred VC during follow-up care. Four participants preferred an 
outpatient clinic consultation and the remaining four participants had no preference. 
Participants were asked about their opinion about using VC. All participants mentioned 
the advantage of having no travel and waiting time. Also, having a consultation in 
their own environment (N = 1) and no travel cost (N = 2) were seen as an advantage. 
Disadvantages of VC were experiencing technical problems (e.g. with audio, internet 
connection), which was reported by 55% of the participants. These technical problems 
resulted in hampered conversation (N = 5), less personal/easy communication (N = 
4) and having no to less body language/non-verbal communication (N = 2) than in a 
face-to-face encounter on the outpatient clinic. One participant missed the ability of a 
physical exam and another participant mentioned less involvement of his wife during 
the consultation. Nine patients reported no drawbacks of VC. Half of the patients 
experienced some degree of technical problems, largely related with audio quality. As a 
consequence, suggested improvements were better audio quality. Eighteen participants 
found VC a valuable addition to the care for NET patients. Two participants did not express 
an opinion. Comments of participants were to alternate follow-up consultations via VC 
and at the outpatient clinic (N = 4) and preference for an outpatient clinic consultation 
in case of complaints or discussing results of important investigations such as a CT scan 
(N = 4).
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Table 2. Patients’ expectations of video-consultation
TSQ: Telemedicine Satisfaction Questionnaire, HC: health-care, VC: video-consultation.
Table 3. Patients’ satisfaction with video-consultation
TSQ: Telemedicine Satisfaction Questionnaire, HC: health-care, VC: video-consultation.
Item TSQ Mean score (SD) 
               (N = 20) 
 1. I expect to talk easily to my HC provider 4.2 (1.1) 
 2. I expect to hear my HC provider clearly 4.5 (1.1) 
 3. I expect that my HC provider is able to understand my HC                                    
     condition 
4.4 (1.0) 
 4. I expect to see my HC provider as if we met in person       3.7 (1.0) 
 5. I do not expect to need assistance while using the system 4.1 (0.9) 
 6. I feel comfortable communicating with my HC provider via VC 4.3 (1.0) 
 7. I expect the HC provided via VC is consistent 4.1 (0.9) 
 8. I expect to have better access to HC services by use of VC 3.4 (0.8) 
 9. VC saves me time travelling to the hospital  4.8 (0.9) 
10. I expect to receive adequate attention 4.6 (0.8) 
11. I expect that VC provides for my HC need 4.3 (0.9) 
12. I expect that VC is an acceptable way to receive HC services 4.4 (0.7) 
 
Item TSQ Mean score (SD) 
               (N = 20) 
 1. I can easily talk to my HC provider 4.4 (1.1) 
 2. I can hear my HC provider clearly 4.2 (0.8) 
 3. My HC provider is able to understand my HC condition 5.0 (0.2) 
 4. I can see my HC provider as if we met in person 4.0 (1.0) 
 5. I do not need assistance while using the system 4.0 (1.0) 
 6. I feel comfortable communicating with my HC provider via VC 4.5 (0.8) 
 7. I think the HC provided via VC is consistent 4.0 (1.1) 
 8. I obtain better access to HC services by use of VC 3.4 (1.1) 
 9. VC saves me time travelling to the hospital  5.0 (0.0) 
10. I do receive adequate attention 5.0 (0.2) 
11. VC provides for my HC need 4.4 (0.7) 
12. I find VC an acceptable way to receive HC services. 4.6 (0.6) 
13. I will use VC services again 4.6 (0.7) 
14. Overall, I am satisfied with the quality of service being provided via  
      VC 
4.7 (0.6) 
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Physicians’ acceptability and satisfaction with video-consultation
Three physicians performed VCs with patients during the study period. Median score 
for satisfaction with VC was 4.0 (range 3.5-4.9) indicating a high level of satisfaction with 
VC (Table 4). A lower average score was found with regard to the equality for follow-up 
care of VC to an outpatient clinic consultation. In the second part of the questionnaire, 
the physicians’ opinion regarding VC was evaluated. Mentioned advantages were that 
VC is sometimes less time consuming in case of patients without problems/complaints, 
communication with the patient was more efficient, no support of other staff was needed 
and no cancellation of the appointment if the patient had ailments such as the flu (N = 2). 
Disadvantages were technical problems, which was reported by the physicians in 40% of 
the performed VCs. Mentioned technical problems were prolonged connection time and 
poor quality of the audio and/or internet resulting in difficulty to hear or see the patient. 
Other drawbacks reported by physicians were having limited information with regard 
to body language (N = 3) and less easy communication with the person (e.g. caregiver) 
who accompanied the patient during the VC (N = 2). After one VC, a physician reported 
less personal communication with the patient. All physicians reported as advantage for 
the patients that VC is time saving and no need to travel. Mentioned disadvantages for 
patients are no possibility for a physical exam, less involvement of an accompanying 
person during a VC and feeling stress/anxiety due to technical/connections problems. 
All physicians consider VC of additional value in the care of NET patients and would 
recommend it to colleagues.
Table 4. Physicians’ satisfaction with video-consultation 
VC: video-consultation.
Statements questionnaire Mean score (SD) 
  (N = 40 questionnaires) 
1. I enjoyed the VC with my patient 4.6 (0.5) 
2. I felt at ease to talk with the patient via VC 4.1 (0.8) 
3. I find that information is adequate provided via VC 4.2 (0.6) 
4. I was able to receive a good impression of the overall health    
    condition of the patient during VC 
4.1 (0.6) 
5. I had no difficulty to discuss emotional/psychological issues 4.1 (0.7) 
6. I find VC equal to consultation at the outpatient clinic for follow-up                
    care 
3.2 (0.9) 
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Discussion
The present study demonstrates that use of VC during follow-up care of NET patients is 
feasible and well accepted by both patients and physicians.
Recently, a patient-reported survey among NET patients from diff erent countries 
demonstrated the burden of traveling to a medical appointment and the wish for better 
access to NET experts/centers [7]. The current study suggests that implementation of VC 
can lighten this burden and make NET experts/centers better accessible.
Studies examining the use of VC during follow-up care in patients with cancer or 
orthopedic surgery showed positive outcomes set out hereafter. A randomized trial 
which compared VC and outpatient clinic visits in men following radical prostatectomy 
(N= 55) reported equivalent effi  ciency, similar overall satisfaction with the encounter 
by the patient and high level of satisfaction for both encounters by the urologist [8]. 
A single-arm pilot study examining virtual clinical encounters in addition to routine 
follow-up in 15 patients after pancreatectomy demonstrated that VC was feasible. 
Also, enhanced communication with health professionals and quality of postoperative 
care was reported by patients [9]. A study investigating the use of the videochat and 
voicecall service ‘Skype’ in addition to conventional follow-up care in patients after 
having undergone total joint arthroplasty showed less unscheduled clinic visits in the 
VC group (N = 34) than in patients only receiving conventional follow-up care (N = 44, 
comprising patients without internet or appropriate electronic devices for using Skype) 
[10]. Moreover, the patients who had used Skype had a higher level of postoperative 
satisfaction. Remarkably, the available data on VC during follow-up care is mostly 
positive. This can be explained by publication bias and/or selection of patients who are 
familiar with using internet, videocommunication or electronic devices. Noteworthy, 
all participants in our study had experience with using internet and it is conceivable 
that patients without internet experience may be reluctant to use VC which warrants 
adequate patient selection in further studies.
The inability of performing a physical examination may be a concern of patients and 
physicians conducting VC. However, others demonstrated no changes in the clinical 
management due to lack of physical examination in patients with several cancer types 
who had a physical exam within 60 days of their VC [11].
No unforeseen VC related consultations at the outpatient clinic or hospital admissions 
were necessary during the study period. Probably, this is associated with inclusion of 
only clinical stable NET patients.
Generalization of our preliminary fi ndings may be hampered by limitations of the study. 
First, no control group was included and no randomization was performed. Therefore, 
no comparison can be made with patients’ and physicians’ satisfaction with follow-up 
consultation at the outpatient clinic. Second, the sample size was small and consecutively 
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impossible to perform statistical analysis (e.g. correlation patient characteristics with 
participation, dropout). Furthermore, by only including clinical stable NET patients there 
is a selection bias. It is unknown if VC is feasible in clinical unstable NET or neuroendocrine 
carcinoma (NEC) patients, which both require more frequent encounters with health 
care professionals.
Lastly, the time patients spent on performing blood analysis in laboratories nearby their 
home (if applicable) was not measured. However, none of these patients reported this as 
a disadvantage or drawback of VC.
In conclusion, our findings suggest that VC is of value in the follow-up care of clinical 
stable NET patients when it is used additional to outpatient clinic consultations. Before 
implementation of VC in the follow-up care of NET patients, technical problems have to 
be solved to improve patients’ and physician satisfaction.
Acknowledgements
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. We thank Mieke van der Linden and Anja Koopman 
for their technical support with performing video-consultation.
Conflict of interest
None to declare.
Chapter 5
536022-L-sub01-bw-Bouma
Processed on: 1-10-2019 PDF page: 95
95  
References
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic 
neuroendocrine tumours. Endocrinol Metab Clin North Am 2011;40:1-18.
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, 
Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke 
C, Grossman AB, UK and Ireland Neuroendocrine Tumour Society. Guidelines for the management of 
gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012;61:6-32.
European Neuroendocrine Tumour Society, retrieved from www.enets.org.
Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: a systematic review of the literature. CMAJ 
2001;165:765-771.
Doolittle GC, Allen A. Practising oncology via telemedicine. J Telemed Telecare 1997;3:63-70.
Yip MP, Chang AM, Chan J, MacKenzie AE. Development of the telemedicine satisfaction questionnaire 
to evaluate patient satisfaction with telemedicine: a preliminary study. J Telemed Telecare 2003;9:46-50.
Singh S, Granberg D, Wolin E, Warner R, Sissons M, Kolarova T, Goldstein G, Pavel M, Öberg K, Leyden 
J. Patient-reported burden of a neuroendocrine tumour (NET) diagnosis: Results from the fi rst global 
survey of patients with NETs. J Glob Oncol 2016;3:43-53.
Viers BR, Lightner DJ, Rivera ME, Tollefson MK, Boorjian SA, Karnes RJ, Thompson RH, O’Neil DA, Hamilton 
RL, Gardner MR, Bundrick M, Jenkins SM, Pruthi S, Frank I, Gettman MT. Effi  ciency, satisfaction, and 
costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol 
2015;68:729-735.
Katz MH, Slack R, Bruno M, McMillan J, Fleming JB, Lee JE, Bednarski B, Papadopoulos J, Matin SF. 
Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of 
“TeleDischarge”. J Surg Res 2016;202:196-203.
Sharareh B, Schwarzkopf R. Eff ectiveness of telemedical applications in postoperative follow-up after 
total joint arthroplasty. J Arthroplasty 2014;29:918-922.
Taylor M, Khoo K, Saltman D, Bouttell E, Porter M. The use of telemedicine to care for cancer patients at 
remote sites. J Clin Oncol 2007;25:6538.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Use of video-consultation is feasible during follow-up care of patients with a neuroendocrine tumour
5
536022-L-sub01-bw-Bouma
Processed on: 1-10-2019 PDF page: 96
 96 
